dasatinib pharmascience 80 mg filmom obložene tablete
pharmascience international limited, lampousas, 1, nicosia, cipar - дазатиниб - filmom obložena tableta - 80 mg - urbroj: jedna filmom obložena tableta sadrži 80 mg dasatiniba (bezvodni oblik)
dasatinib zentiva 100 mg filmom obložene tablete
zentiva k.s., u kabelovny 130, dolni mecholupy, prag 10, Češka - дазатиниб - filmom obložena tableta - 100 mg - urbroj: jedna filmom obložena tableta sadrži 100 mg dasatiniba
dasatinib zentiva 20 mg filmom obložene tablete
zentiva k.s., u kabelovny 130, dolni mecholupy, prag 10, Češka - дазатиниб - filmom obložena tableta - 20 mg - urbroj: jedna filmom obložena tableta sadrži 20 mg dasatiniba
dasatinib accord
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastična sredstva - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.
nodriga 20 mg/1 tableta film tableta
alkaloid d.o.o. sarajevo - dasatinib - film tableta - 20 mg/1 tableta - 1 film tableta sadrži 20 mg dasatiniba
nodriga 50 mg/1 tableta film tableta
alkaloid d.o.o. sarajevo - dasatinib - film tableta - 50 mg/1 tableta - 1 film tableta sadrži 50 mg dasatiniba
nodriga 70 mg/1 tableta film tableta
alkaloid d.o.o. sarajevo - dasatinib - film tableta - 70 mg/1 tableta - 1 film tableta sadrži 70 mg dasatiniba
nodriga 140 mg/1 tableta film tableta
alkaloid d.o.o. sarajevo - dasatinib - film tableta - 140 mg/1 tableta - 1 film tableta sadrži 140 mg dasatiniba
edurant
janssen-cilag international n.v. - rilpivirin hidroklorid - hiv infekcije - antivirusni lijekovi za sustavnu uporabu - edurant, u kombinaciji s drugim antiretrovirusne lijekove, je indiciran za liječenje humane imunodeficijencije tip 1 (hiv‑1) infekcija u bolesnika treatment‑naïve antiretrovirusne 12 godina i stariji sa viremija ≤ 100 000 hiv‑1 rna kopija/ml. kao i s drugim антиретровирусными lijekovima генотипическое ispitivanje otpora treba biti vođena pri korištenju edurant.
lumykras
amgen europe bv - sotorasib - karcinom, ne-malih stanica pluća - antineoplastična sredstva - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.